Nature Genetics
12, 455 - 457 (1996)
doi:10.1038/ng0496-455
Genetic mapping of a pulmonary adenoma resistance locus (Par1) in mouseGiacomo Manenti1, Manuela Gariboldi1, Ramu Elango2, Antonio Fiorino1, Laura De Gregorio1, F. Stefania Falvella1, Kent Hunter2, David Housman2, Marco A. Pierotti1
& Tommaso A. Dragani1, 3
1Division of Experimental Oncology A, Istituto Nazionale Tumori, Via G. Venezian 1, 20133, Milan, Italy.
2Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
3Correspondence should be addressed to T.A.D. Lung cancer, a major cause of death in the Western world, has a poor prognosis1. So far, therapeutic strategies have had only a limited effect. Lung cancer risk is strongly associated with cigarette smoking2,3 and lung cancer pedigrees are rare. However, a possible polygenic nature of inherited predisposition to this cancer has been envisaged4−7. Mouse inbred strains with inherited predisposition and resistance to lung cancer provide an important tool for the dissection of the genetics of this complex disease7,8. The A/J strain carries the pulmonary adenoma susceptibility 1 (Pas7) locus and develops many lung tumours9. We have mapped the M. spretus-derived locus that strongly resists the lung tumorigenesis in Pas1/+ mice. This locus, pulmonary adenoma resistance 1 (Par1) maps to mouse chromosome 11, near the Rara locus, with a lod score of 5.3. In Pas1/+ mice Par1 accounts for 23% of the phenotypic variance and 10 fold reduction in total tumour volume. These results provide evidence for a major resistance locus affecting the expression of an inherited predisposition to lung cancer.
REFERENCES
- Gilliland, F.D. & Samet, J.M. Trends in cancer incidence and mortality. in Cancer Surveys Vol. 19. (eds Doll, R., Fraumeni, J.F. & Muir, C.S.) 175−195 (Cold Spring Harbor Laboratory Press, 1994). | ChemPort |
- Loeb, L.A., Ernster, V.L., Warner, K.E., Abbotts, J. & Laszlo, J. Smoking and lung cancer: an overview. Cancer Res. 44, 5940−5958 (1984). | PubMed | ISI | ChemPort |
- International Agency for Research on Cancer. in IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Tobacco Smoking. 83−126 (IARC, Lyon, 1986).
- Sellers, T.A., Potter, J.D., Beiley-Wilson, J.E., Rich, S.S., Rothschild, H. & Eltson, R.C. Lung cancer detection and prevention: evidence for an interaction between smoking and genetic predisposition. Cancer Res. 52, 2694s−2697s (1992). | PubMed | ChemPort |
- Amos, C.I., Caporaso, N.E. & Weston, A. Host factors in lung cancer risk: a review of interdisciplinary studies. Cancer Epidemiol., Biomarkers Prevent. 1, 505−513 (1992). | ISI | ChemPort |
- Law, M.R. Genetic predisposition to lung cancer. Br. J. Cancer 61, 195−206 (1990). | PubMed | ISI | ChemPort |
- Dragani, T.A., Manenti, G. & Pierotti, M.A. Genetics of murine lung tumors. Adv. Cancer Res. 67, 83−112 (1995). | PubMed | ISI | ChemPort |
- Malkinson, A.M. The genetic basis of susceptibility to lung tumors in mice. Toxycology 54, 241−271 (1989). | Article | ChemPort |
- Gariboldi, M. et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nature Genet. 3, 132−136 (1993). | PubMed | ISI | ChemPort |
- McCarthy, L. et al. Efficient high-resolution genetic mapping of mouse interspersed repetitive sequence PCR products, towards integrated genetic and physical mapping of the mouse genome. Proc. Natl. Acad. Sci. USA 92, 5302−5306 (1995). | PubMed | ChemPort |
- Manenti, G., Falvella, F.S., Gariboldi, M., Dragani, T.A. & Pierotti, M.A. Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2. Genomics 29, 438−444 (1995). | Article | PubMed | ISI | ChemPort |
- Lossie, A.C., MacPhee, M., Buchberg, A.M. & SA Mouse chromosome 11. Mamm. Genome 5, S164−S180 (1994). | PubMed | ISI | ChemPort |
- Toma, S., Losardo, R.L., Vincent, M. & Palumbo, R. Effectiveness of 6-carotene in cancer chemoprevention. Eur. J. Cancer Prev. 4, 213−224 (1995). | PubMed | ISI | ChemPort |
- Moon, R.C., Rao, K.V., Detrisac, C.J. & Kelloff, G.J. Animal models for chemoprevention of respiratory cancer. Monogr. Natl. Cancer Inst. 13, 45−49 (1992). | PubMed |
- De Luca, L.M. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5, 2924−2933 (1991). | PubMed | ChemPort |
- Pastorino, U. et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J. Clin. Oncol. 11, 1216−1222 (1993). | PubMed | ISI | ChemPort |
- Dietrich, W.F. et al. Genetic identification of Mom-1, a major modifier locus affecting Min induced intestinal neoplasia in the mouse. Cell 75, 631−639 (1993). | Article | PubMed | ISI | ChemPort |
- MacPhee, M., Chepenik, K.P., Liddell, R.A., Nelson, K.K., Siracusa, L.D. & Buchberg, A.M. The secretory phospholipase A2 gene is a candidate for the Mom 1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 81, 957−966 (1995). | PubMed | ISI | ChemPort |
- Nagase, H., Bryson, S., Cordell, H., Kemp, C.J., Fee, F. & Balmain, A. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nature Genet. 10, 424−429 (1995). | Article | PubMed | ISI | ChemPort |
- Dragani, T.A., Manenti, G. & Delia Porta, G. Quantitative analysis of genetic susceptibility to liver and lung carcinogenesis in mice. Cancer Res. 51, 6299−6303 (1991). | PubMed | ISI | ChemPort |
- Lee, G.-H., Bennett, L.M., Carabeo, R.A. & Drinkwater, N.R. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics 139, 387−395 (1995). | PubMed | ISI | ChemPort |
- Hsu, L.-C. et al. Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res. 54, 2765−2770 (1994). | PubMed | ISI | ChemPort |
- Conover, W.J. & Iman, R.L. Rank transformationsas a bridge between parametric and nonparametric statistics. Am. Statistician 35, 124−129 (1981). | ISI |
- Dietrich, W.F. et al. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nature Genet. 7, 220−245 (1994). | PubMed | ISI | ChemPort |
- Lander, E.S. & R Construction of multilocus genetic maps in humans. Proc. Natl. Acad. Sci. USA 84, 2363−2367 (1987). | PubMed | ChemPort |
- Lincoln, S.E., Daly, M. & Lander, E.S. Constructing genetic maps with MAPMAKER/EXP 3.0. Whitehead Institute Technical Report (1992).
- SAS Institute. SAS Users Guide: Statistics. (1988).
- Lander, E.S. & Botstein, D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121, 185−199 (1989). | PubMed | ISI | ChemPort |
- Lincoln, S.E., Daly, M., Lander, E.S. Mapping genes controlling quantitative traits with MAPMAKER/QTL 1.1. Whitehead Institute Technical Report. (1992).
|
